This week in cannabis news, Curaleaf (CURA) achieved progress with its plans to list on the Toronto Stock Exchange. Meanwhile, states approved legislative returns and Navigator Research released a new study on the impact of legalization.
Curaleaf (CURA) is one step closer to its goal of listing on the Toronto Stock Exchange (TSX). The cannabis producer recently shared that it had made progress with its listing plans, and is currently engaging with various regulatory authorities for their review and approval. Being listed on the TSX presents an exciting opportunity for Curaleaf and its investors.
Several US states made progress with cannabis legalization this week. In Illinois, newly proposed legislation approved returns for people who have faced cannabis-related felony convictions. The state also legalized cannabis-infused beverages, opening up another lucrative market.
Meanwhile, Oregon passed a measure that will allow medical cannabis dispensaries to sell marijuana infused meals and drinks. This goes in-line with the state’s recent decriminalization of small amounts of personal cannabis possession.
Navigator Research released a new study revealing the potential effects of cannabis legalization on public health. The group argued that regulated cannabis production, distribution, and consumption threaten to exacerbate existing inequalities among communities of color, and lack of access to safe and legal cannabis continues to impact vulnerable populations.
This week in cannabis news was marked by progress in legalization efforts, as well as a strategic advance by Curaleaf. While the US and Canada continue to move in a progressive direction when it comes to cannabis, policy makers should bear in mind the need to to ensure equitable access and create regulatory frameworks that protect public health.
“Take Notice: Curaleaf Joins TSX, STATES Act Back on the Agenda | Cannabis Weekly Round-Up
